NXT.AU

15.56

+0.39%↑

BRG.AU

37.33

+0.35%↑

SFR.AU

9.9

+0.41%↑

LLC.AU

6.32

+0.64%↑

NXT.AU

15.56

+0.39%↑

BRG.AU

37.33

+0.35%↑

SFR.AU

9.9

+0.41%↑

LLC.AU

6.32

+0.64%↑

NXT.AU

15.56

+0.39%↑

BRG.AU

37.33

+0.35%↑

SFR.AU

9.9

+0.41%↑

LLC.AU

6.32

+0.64%↑

NXT.AU

15.56

+0.39%↑

BRG.AU

37.33

+0.35%↑

SFR.AU

9.9

+0.41%↑

LLC.AU

6.32

+0.64%↑

NXT.AU

15.56

+0.39%↑

BRG.AU

37.33

+0.35%↑

SFR.AU

9.9

+0.41%↑

LLC.AU

6.32

+0.64%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Cerrado

Sector Inmobiliario

35.15 0.63

Resumen

Variación precio

24h

Actual

Mínimo

34.72

Máximo

35.25

Métricas clave

By Trading Economics

Ingresos

141M

153M

Ventas

482M

951M

P/B

Media del Sector

126.745

83.663

BPA

0.26

Rentabilidad por dividendo

1.519

Margen de beneficio

16.106

Empleados

7,141

EBITDA

6.4M

276M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+10.31 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.52%

4.49%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-289M

20B

Apertura anterior

34.52

Cierre anterior

35.15

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

64 / 193 Clasificación en Real estate

Fisher & Paykel Healthcare Corp Ltd Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 nov 2024, 21:55 UTC

Charlas de Mercado

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov 2024, 22:39 UTC

Charlas de Mercado

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 sept 2024, 23:56 UTC

Charlas de Mercado

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 may 2024, 00:44 UTC

Charlas de Mercado
Ganancias

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 may 2024, 23:35 UTC

Charlas de Mercado

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 may 2024, 22:43 UTC

Charlas de Mercado

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 may 2024, 20:59 UTC

Ganancias

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 may 2024, 20:58 UTC

Ganancias

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 may 2024, 20:57 UTC

Ganancias

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 may 2024, 20:56 UTC

Ganancias

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24 abr 2024, 02:38 UTC

Charlas de Mercado

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

25 mar 2024, 22:04 UTC

Charlas de Mercado

F&P Healthcare Can Meet Market Expectations for Revenue Growth -- Market Talk

Comparación entre iguales

Cambio de precio

Fisher & Paykel Healthcare Corp Ltd Esperado

Precio Objetivo

By TipRanks

10.31% repunte

Estimación a 12 meses

Media 38.51 AUD  10.31%

Máximo 42.7 AUD

Mínimo 34.7 AUD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fisher & Paykel Healthcare Corp Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

3

Comprar

2

Mantener

1

Vender

Sentimiento

By Acuity

64 / 193 Clasificación en Inmobiliario

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.